文献速递胃肠外科围术期管理与 ERAS

腹腔镜与机器人抗反流手术的成本与结局配对队列分析

Laparoscopic vs. robotic-assisted antireflux surgery: a matched cohort analysis of procedure costs and outcomes.
PubMed 文献 · Surg Endosc · 2026-01-20

该回顾性队列与成本效果研究基于前瞻性数据库,纳入138例成人抗反流手术患者(R-ARS 69例,L-ARS 69例,1:1倾向评分匹配)。R-ARS手术室使用时间和住院时间更长、总费用更高,早期并发症和再入院率无差异,但术后吞咽困难相关内镜干预更频繁。总体R-ARS短期安全性未优于L-ARS,资源消耗更大,成本效果较差。

要点

  • R-ARS总费用中位数为$15676.1,显著高于L-ARS的$7694.9。
  • R-ARS手术室使用时间中位数169分钟,长于L-ARS的128分钟。
  • 术后吞咽困难发生率两组相似,但R-ARS后内镜干预比例更高。

核心结论

  • R-ARS短期安全性未优于L-ARS,资源消耗更大,成本效果较差。

研究设计与样本

  • 回顾性队列与成本效果研究,使用单一位经验丰富食管外科医生前瞻性维护数据库。
  • 纳入所有择期初次R-ARS病例(2016年9月至2024年12月),与1:1倾向评分匹配的L-ARS队列比较。
  • 共纳入138例患者,R-ARS 69例,L-ARS 69例。

主要发现

  • R-ARS手术室使用时间中位数169分钟 vs L-ARS 128分钟(p < 0.001)。
  • R-ARS住院时间中位数2天 vs L-ARS 1天(p = 0.045)。
  • 术中并发症R-ARS 5.8% vs L-ARS 1.4%(p = 0.362)。
  • 早期并发症两组均为10.1%,ICU入住R-ARS 2.9% vs L-ARS 1.4%(p > 0.999),90天再入院R-ARS 6.1% vs L-ARS 3.3%(p = 0.749)。
  • 患者报告术后吞咽困难R-ARS 26.1% vs L-ARS 30.4%(p = 0.705),但后续内镜干预R-ARS 16/18(88.9%)vs L-ARS 9/21(42.9%)(p = 0.008)。

关键数值与推荐

  • R-ARS总费用中位数$15676.1 vs L-ARS $7694.9(p < 0.001)。
  • 术中并发症的ICER为-$181390.9( favoring L-ARS)。
  • 90天再入院的ICER为$285042.9(favoring R-ARS)。

临床怎么用

  • 在抗反流手术中,选择机器人入路需权衡更高费用和资源占用与有限的短期结局获益。
  • 对于术后吞咽困难需内镜干预的风险,R-ARS后应保持关注。

局限性

  • 回顾性设计,单中心、单外科医生经验,结果外推需谨慎。
  • 样本量有限,部分结局比较的统计效能可能不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of robotic surgery has expanded rapidly; however, its cost-effectiveness in foregut surgery remains unclear. We aimed to compare early postoperative outcomes and procedure-related costs between robotic (R-) and laparoscopic (L-) antireflux surgery (ARS). METHODS: This retrospective cohort and cost-effectiveness study was conducted using a prospectively maintained database of adults who underwent minimally invasive ARS by a single experienced esophageal surgeon. All primary elective R-ARS cases (September 2016-December 2024) were identified, and perioperative outcomes and procedure costs (US$) were compared to a 1:1 propensity-score matched L-ARS cohort. Moreover, incremental cost-effectiveness ratios (ICERs) were calculated for predefined outcomes. RESULTS: In total, 138 patients (69 R-ARS, 69 L-ARS) were included. R-ARS was associated with a longer median operating room utilization time (169 vs 128 min., p < 0.001) and length-of-stay (2 vs. 1 days, p = 0.045) and slightly more intraoperative complications (5.8 vs. 1.4%, p = 0.362). Early complications (10.1% both), ICU admissions (R-ARS, 2.9% vs. L-ARS, 1.4%, p > 0.999), and 90-day readmissions (R-ARS, 6.1% vs. L-ARS, 3.3%, p = 0.749) were similar between the groups. The median all-inclusive cost was higher with R-ARS ($15,676.1 vs. $7694.9, p < 0.001). Although the incidence of patient-reported postoperative dysphagia was similar after R-ARS or L-ARS (26.1 vs. 30.4%, p = 0.705), resulting endoscopic interventions were more frequent after R-ARS (16/18 [88.9%] vs. 9/21 [42.9%], p = 0.008). The ICERs for intraoperative complications and 90-day readmissions were -$181,390.9 (favoring L-ARS) and $285,042.9 (favoring R-ARS), respectively. CONCLUSION: Overall, R-ARS may not offer superior short-term safety compared to L-ARS, utilizes greater resources, and appears to be less cost-effective.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Latorre-Rodríguez AR, Vittori A, Bremner RM, et al. Laparoscopic vs. robotic-assisted antireflux surgery: a matched cohort analysis of procedure costs and outcomes. Surg Endosc. 2026. PMID: 41559337. doi:10.1007/s00464-025-12551-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。